Trial intelligence / Profile preview

Betamethasone valerate medicated plaster for fingernail psoriasis

2014-000291-25Phase 2Terminated

Sponsor
IBSA Group
Start
Apr 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of betamethasone in nail psoriasis (2 arms), sponsored by IBSA Group. Primary endpoint: Target Nail Psoriasis Severity Index for right and left target fingernails. Started Apr 2014; status: terminated.

02

Drugs

betamethasone
03

Conditions

nail psoriasis

Beyond the preview

Go deeper on 2014-000291-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000291-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call